LexDanaLexDanabeta
Inventor

JOAN TALTAVULL MOLL

Inventor
ES

Overview

3→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
12,441,704Compounds active towards nuclear receptors202511,780,843Compounds active towards nuclear receptors202311,685,727Compounds active towards nuclear receptors2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2025Patents assigned to NUEVOLUTION AS (3)· patent assignee history
2023–2025Based in ES· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
NUEVOLUTION AS32023–2025
Locations
LocationPatentsSpan
ES32023–2025